All Insights
Details of Bill to relax gene editing rules in UK announced
IP and devolution questions raised as Genetic Technology (Precision Breeding) Bill begins its Parliamentary process
Cell and gene therapies: solving the skills shortage in the UK
Companies involved in developing cell and gene therapies face challenges in recruiting skilled talent fast enough to keep pace with
The UK medical devices regime and the impact of the Northern Ireland Protocol
Life Sciences analysis: Peter Rudd-Clarke, partner, and Anna Lundy, associate director, at Osborne Clarke discuss how the medical device industry
Updated CQC guidance has implications for the health technology and wellbeing industries
Reworked guidance reflects the evolution in models for healthcare service delivery, especially with regard to technological innovation
Unitary Patents and the Unified Patent Court: FAQs
Significant changes to the patent landscape across Europe are coming, what can be expected and what can be done to
New regulations are coming for medical devices in the UK
While we await detailed legislation, companies intending to place medical devices on the UK market can begin to prepare for
Data-driven business models: the role of legal teams in delivering success | Key findings
This infographic highlights some of the key overall findings and sector figures from our detailed report produced in partnership with
Data-driven business models: the role of legal teams in delivering success | Report
This detailed report, produced in partnership with European Company Lawyers Association (ECLA), explores the challenges and opportunities associated with new
Approval of insomnia app for use in the NHS offers a case study for digital health developers
Opportunities are available for those that navigate the regulatory system and provide evidence of their products' efficacy and performance
Medical device, clinical trial and safety rules reforms could boost UK life sciences
As the economy falters and NHS waiting lists grow, 2021 legislation offers wide powers to reform product rules and spur
Queen's Speech bill aims to bring gene-edited plants and animals to market
The Genetic Technology (Precision Breeding) Bill seeks to simplify the regulatory regime for precision-bred plants and animals
New WTO Covid-19 vaccine IP waiver proposed
A new vaccine IP waiver proposal has been published by the WTO Director-General following informal negotiations between the EU, India